Italy to Seek $1.6 Billion From Novartis, Roche Over Collusion Ruling; Swiss Drug Makers Accused of Colluding Over Eye Medication

In March, Italy's antitrust authority fined Novartis and Roche more than [euro]90 million each after finding they had colluded to push doctors toward their jointly marketed Lucentis treatment, an expensive drug used to combat sight problems such as age-related macular degeneration, at the expen...

Full description

Saved in:
Bibliographic Details
Published in:The Wall Street journal. Eastern edition 2014-05-29
Main Author: Ball, Deborah
Format: Newspaper Article
Language:English
Subjects:
Antitrust
Collusion
Macular degeneration
Pharmaceutical industry
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In March, Italy's antitrust authority fined Novartis and Roche more than [euro]90 million each after finding they had colluded to push doctors toward their jointly marketed Lucentis treatment, an expensive drug used to combat sight problems such as age-related macular degeneration, at the expense of Roche's Avastin, an older and less expensive drug that some doctors had used to treat the same conditions.
ISSN:2574-9579